We are live on ! Find out more
Barclays

Barclays Portfolio holdings

AUM $416B
1-Year Est. Return 33.63%
 

Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.

This Fund
S&P 500
This Quarter Est. Return
-2.43%
1 Year Est. Return
+33.63%
3 Year Est. Return
+104.86%
5 Year Est. Return
+133.18%
10 Year Est. Return
+529.74%
AUM
$161B
AUM Growth
+$2.64B
Cap. Flow
+$8.05B
Cap. Flow %
5.01%
Top 10 Hldgs %
23.87%
Holding
4,832
New
336
Increased
1,838
Reduced
1,886
Closed
249

Top Buys

Rank Stock Value
1
CRH icon
CRH
CRH
+$978M
2
MSFT icon
Microsoft
MSFT
+$812M
3
BAC icon
Bank of America
BAC
+$602M
4
AAPL icon
Apple
AAPL
+$518M
5
NVDA icon
NVIDIA
NVDA
+$412M

Sector Composition

Rank Sector Weight
1 Technology 27.45%
2 Financials 11.83%
3 Healthcare 11.27%
4 Consumer Discretionary 10.12%
5 Communication Services 7.24%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NUVB.WS
4351
DELISTED
Nuvation Bio Inc Warrants
NUVB.WS
$164 ﹤0.01%
1,638
AWH
4352
DELISTED
Aspira Women's Health Inc. Common Stock
AWH
$160 ﹤0.01%
30
+15
+100% +$57
BOLT icon
4353
Bolt Biotherapeutics
BOLT
$7.67M
$145 ﹤0.01%
7
SQZ
4354
DELISTED
SQZ Biotechnologies Company
SQZ
$144 ﹤0.01%
1,794
PDYN icon
4355
Palladyne AI
PDYN
$247M
$142 ﹤0.01%
166
-1
-0.6% -$1
DYAI icon
4356
Dyadic International
DYAI
$38.3M
$138 ﹤0.01%
72
RMTI icon
4357
Rockwell Medical
RMTI
$28.4M
$135 ﹤0.01%
+7
New +$213
PRST
4358
DELISTED
Presto Technologies, Inc. Common Stock
PRST
$113 ﹤0.01%
79
-531
-87% -$1.78K
CYPH
4359
Cypherpunk Technologies Inc
CYPH
$62.9M
$112 ﹤0.01%
+81
New +$188
ALIM
4360
DELISTED
Alimera Sciences
ALIM
$112 ﹤0.01%
+36
New +$119
VHC icon
4361
VirnetX Holding Corp
VHC
$54.4M
$110 ﹤0.01%
22
+11
+100% +$85
BBU
4362
DELISTED
Brookfield Business Partners
BBU
$106 ﹤0.01%
+7
New +$117
MREO
4363
Mereo BioPharma
MREO
$54.7M
$98 ﹤0.01%
76
+38
+100% +$50
TMQ
4364
Trilogy Metals
TMQ
$541M
$98 ﹤0.01%
200
KNDI
4365
Kandi Technologies Group
KNDI
$67.5M
$96 ﹤0.01%
28
+14
+100% +$49
UUP icon
4366
Invesco DB US Dollar Index Bullish Fund
UUP
$420M
$90 ﹤0.01%
3
+1
+50% +$29
HEPA
4367
DELISTED
Hepion Pharmaceuticals
HEPA
0
VGZ icon
4368
Vista Gold
VGZ
$251M
$80 ﹤0.01%
188
+94
+100% +$46
ZSQR
4369
Z Squared Inc
ZSQR
$254M
$78 ﹤0.01%
3
AAU
4370
DELISTED
Almaden Minerals Ltd
AAU
$73 ﹤0.01%
500
SKM icon
4371
SK Telecom
SKM
$12.1B
$64 ﹤0.01%
3
SKF icon
4372
ProShares UltraShort Financials
SKF
$10.3M
$57 ﹤0.01%
1
EFTR
4373
DELISTED
eFFECTOR Therapeutics, Inc. Common Stock
EFTR
$49 ﹤0.01%
+3
New +$52
CLLS
4374
Cellectis
CLLS
$277M
$44 ﹤0.01%
28
VRAY
4375
DELISTED
ViewRay, Inc.
VRAY
$39 ﹤0.01%
4,735
-1,987,861
-100% -$472K

Similar funds

Barclays's Q3 2023 Portfolio in Review

As of Q3 2023, Barclays held 4,832 positions worth $161B, up 1.7% from $158B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Barclays deployed $8.05B of net new capital in Q3 2023, opening 336 new positions and adding to 1,838 existing holdings. Its largest new stake was CRH: 17,203,754 shares worth $942M.

By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 28% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Invesco QQQ Trust, an estimated $1.32B trimmed.

  • Barclays's largest Q3 2023 buy was CRH: 17,203,754 shares worth $942M.
  • Barclays added most to Microsoft in Q3 2023, an estimated $812M increase.
  • Barclays's biggest Q3 2023 reduction was Invesco QQQ Trust, cutting an estimated $1.32B.
  • Barclays fully exited Aerojet Rocketdyne Holdings in Q3 2023, selling an estimated $154M.
  • Barclays's ten largest holdings make up 24% of its $161B portfolio in Q3 2023.
  • Barclays opened 336 new positions and closed 249 in Q3 2023.
  • Barclays's portfolio value rose 1.7% quarter-over-quarter to $161B.

Based on Barclays's 13F filing for Q3 2023, filed 7 Nov 2023.